Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina A phase II randomized, double-blinded, placebo-controlled study

Projektinformationen

ReGenHeart

ID Finanzhilfevereinbarung: 731532

DOI 10.3030/731532

Projekt abgeschlossen

EK-Unterschriftsdatum 1 Dezember 2016

Startdatum 1 Januar 2017

Enddatum 31 Dezember 2022

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten € 5 934 088,75

EU-Beitrag € 5 934 086,00

Koordiniert durch

POHJOIS-SAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
Finland

Leistungen

Documents, reports (2)

Summary report on project management methods used during the project
Summary report on ethical & gender issues raised by the project

Summary report on ethical gender issues raised by the project

Websites, patent fillings, videos etc. (1)

Project website